Campylobacter Infection as a Trigger for Guillain-Barré Syndrome in Egypt by Wierzba, Thomas F. et al.
Campylobacter Infection as a Trigger for Guillain-Barre ´
Syndrome in Egypt
Thomas F. Wierzba
1¤a*, Ibrahim Adib Abdel-Messih
1, Bayoumi Gharib
2, Shahida Baqar
3, Amina
Hendaui
4, Ibrahim Khalil
2, Tarek A. Omar
3, Hamed E. Khayat
5, Shannon D. Putnam
1, John W. Sanders
6¤b,
Lai-King Ng
7, Lawrence J. Price
7, Daniel A. Scott
8¤c, Robert R. Frenck
1¤d
1US Naval Medical Research Unit No. 3, Cairo, Egypt, 2Neurology Department, Alexandria University Hospitals, Alexandria, Egypt, 3Naval Medical Research Center, Silver
Spring, Maryland, United States of America, 4Neurology Department, Cairo University Hospitals, Cairo, Egypt, 5Neurology Department, Ain Shams University Children’s
Hospital, Ain Shams, Egypt, 6US Naval Medical Research Unit No. 3, Cairo, Egypt, 7Bacteriology and Enteric Diseases Program, National Microbiology Laboratory,
Winnipeg, Manitoba, Canada, 8Naval Medical Research Center, Bethesda, Maryland, United States of America
Abstract
Background: Most studies of Campylobacter infection triggering Guillain-Barre ´ Syndrome (GBS) are conducted in western
nations were Campylobacter infection and immunity is relatively rare. In this study, we explored Campylobacter infections,
Campylobacter serotypes, autoantibodies to gangliosides, and GBS in Egypt, a country where Campylobacter exposure is
common.
Methods: GBS cases (n=133) were compared to age- and hospital-matched patient controls (n=374). A nerve conduction
study was performed on cases and a clinical history, serum sample, and stool specimen obtained for all subjects.
Results: Most (63.3%) cases were demyelinating type; median age four years. Cases were more likely than controls to have
diarrhea (29.5% vs. 22.5%, Adjusted Odds Ratio (ORa)=1.69, P=0.03), to have higher geometric mean IgM anti-
Campylobacter antibody titers (8.18 vs. 7.25 P,0.001), and to produce antiganglioside antibodies (e.g., anti-Gd1a, 35.3 vs.
11.5, ORa=4.39, P,0.0001). Of 26 Penner:Lior Campylobacter serotypes isolated, only one (41:27, C. jejuni, P=0.02) was
associated with GBS.
Conclusions: Unlike results from western nations, data suggested that GBS cases were primarily in the young and cases and
many controls had a history of infection to a variety of Campylobacter serotypes. Still, the higher rates of diarrhea and
greater antibody production against Campylobacter and gangliosides in GBS patients were consistent with findings from
western countries.
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Introduction
Campylobacter–associated diarrhea is common in developing
countries and residents experience repeated attacks [1]. In Egypt,
for example, Campylobacter is the second leading cause of pediatric
diarrhea with infants and one year olds experiencing 1.2 and 0.4
episodes per year, respectively [2]. Although most Campylobacter-
associated diarrhea is self-limited, complications can occur. One
complication is Guillain-Barre ´ Syndrome (GBS), an acute,
symmetric, ascending paralysis that is estimated to occur 30 times
for every 100 000 Campylobacter cases. The case fatality ratio
approaches 10% [3–5].
The link between GBS and campylobacterosis is based on studies
suggesting that these enterobacteria are more often isolated from
GBS cases than controls along with findings that anti-Campylobacter
serum antibodies occur more frequently in cases [6]. Studies which
have linked Campylobacter infection to GBS have been typically
performed in developed countries where exposure to Campylobacter is
rare and residents are likely immunologically naive to Campylobacter
[1,6]. Studies examining an association between Campylobacter
infection and GBS are infrequently performed in the developing
world, where in contrast to developed countries, infections with
Campylobacter are common and residents are repeatedly exposed. In
the current study, we examined Campylobacter as an agent for GBS in
PLoS ONE | www.plosone.org 1 November 2008 | Volume 3 | Issue 11 | e3674Egypt, a country endemic for campylobacterosis and compared
these findings to those reported from developed countries.
Methods
Study Population
All patients admitted to Cairo and Alexandria University
Hospitals and children admitted to Ain Shams Children’s Hospital
betweenApril 2001 and September 2003 with GBS or Miller-Fisher
syndrome were eligible for enrollment. For GBS, each patient
demonstrated a progressive, symmetric ascending paralysis with a
relative sensory sparing in more than one extremity with hypo- or
areflexia [7]. ForMiller-Fishersyndrome, a variant ofGBS, patients
demonstrated ophthalmoplegia,ataxiaand areflexia[8].Ifa lumbar
puncture was performed, cerebral spinal fluid was evaluated for
protein and cell counts. Findings consistent with GBS included an
elevated CSF protein (.0.55 g/liter) with a normal CSF cell count
(,10 cells/mm3). A neurologist diagnosed each case.
For each case, the next three consecutive age- and hospital-
matched patients meeting selection criteria were eligible as controls.
Controls were withintwo years of the case’s age, wereadmitted with
an acute illness, and could not present with acute neuropathic
symptoms. As we were estimating the frequency of diarrhea before
an acute illness, controls like cases could have a history of diarrhea
or present with diarrhea but could not have diarrhea as their
primary reason for admission. As blood samples from cases were
obtained before receiving plasmapheresis or intravenous immuno-
globulin, similarly controls were excluded if they received blood or
blood products up to 12 months before enrollment.
Clinical data, blood, and three rectal swabs were collected from
all subjects. For children and patients too ill to provide a medical
history, the history was taken from a parent, spouse, or another
adult family member. Nerve conduction studies were performed
on each case.
The study was approved by the Institutional Review Board of
the US Naval Medical Research Unit No. 3 and the Egyptian
Ministry of Health and Population. Voluntary written informed
consent for participation was provided by a parent or another
adult family member for all cases and controls less than 18 years of
age and by the patient if the age was greater than or equal to 18
years, the age of majority. If an adult patient was unable to provide
consent due to severe illness, a spouse or another adult family
member was consented on behalf of the patient.
Electrophysiological Data
A Nerve Conduction Velocity (NCV) test was performed using
conventional techniques and each patient was categorized as
primary demyelinating, primary axonal, inexcitable, equivocal, or
normal using published criteria [9]. One investigator (IK)
standardized testing at each hospital.
Microbiologic Investigations
Campylobacter isolation was based on techniques suggested
elsewhere [10]. Three rectal swabs were collected from each
patient. Two swabs were placed in Cary-Blair transport media and
one swab in Campy-Thio-Broth. Specimens were refrigerated at
4u to 6uC and transported within three days to the US Naval
Medical Research Unit No. 3 (NAMRU-3) laboratory in Cairo.
At NAMRU-3, swabs from the Cary-Blair transport tubes were
streaked on Campylobacter Selective Agar with Preston antibiotic
supplement (CA), charcoal cefoperazone deoxycholate agar
(CCDA), Shigella-Salmonella Agar (SS), and MacConkey’s Agar
(MAC) plates. Campylobacter-Thio tubes were incubated at 42uC for
two hours then inoculated on Campylobacter selective agar plates.
The CA and CCDA plates were incubated at 42uC under
microaerophilic conditions for up to 72 hours and checked every
24 hours for growth. A case was Campylobacter negative, if no
growth was found after 72 hours.
When Campylobacter-like colonies were observed on the CA and/
or CCDA plates, an oxidase test and Gram stain were performed
followed by re-streaking onto blood agar plates. After 24 hours of
microaerophilic growth, isolates were tested for hippurate
hydrolysis. Hippurate positive colonies (presumptive identification
for C jejuni) were sub-cultured onto three Mueller-Hinton blood
agar plates with filters, incubated at 42uC for 24 to 48 hours under
microaerophilic conditions. Indoxyl Acetate Hydrolysis (IAH) was
conducted on hippurate-negative colonies followed by catalase
testing if the IAH was positive. IAH/catalase positive organisms
were classified as C coli whereas IAH positive/catalase negative
colonies were classified as C upsaliensis. Multiple Campylobacter
isolates from a pure plate were pooled and inoculated into three,
1.5 mls of trypticase soy broth supplemented with 15% sterile
glycerol and frozen at 270uC.
Serum Immune Responses
Blood samples were collected for cases within one day of
admission (Interquartile Range (IQR): 0 to 2) and for controls on
the day (IQR: 0 to 1) of enrollment. Serum was separated and
stored at 270uC until assayed by enzyme linked immunoassay
(ELISA) described in detail elsewhere [11,12]. In brief, a glycine
extract (GE) of proteins [13] from a reference strain, C jejuni 81–
176, was prepared. The extract was used to coat wells of MaxiSorp
96-well immuoplates (NUNC) at 3 mg/ml or, for control wells, at
10 mg/ml of bovine serum albumin (Sigma Chemicals). Serum
IgM and IgG were measured by ELISA that used peroxidase-
conjugated isotype-specific goat anti-human immunoglobulin.
Endpoint titers are expressed as the reciprocal of the highest
dilution giving a net absorbance (antigen well – BSA control well)
value of 0.15 at OD405.
Antiganglioside IgG Responses
Antiganglioside serum IgG was determined by ELISA with
minor modification of methodology reported by Willison et al
[14]. Briefly, MaxiSorp 96-well immuoplates were coated with
0.5 mg of each ganglioside GM1, GM2, GD1a, Gd1b or Gt1b
(Sigma Chemicals). Negative control wells were coated with
methanol. After blocking with 1% BSA, plates were washed with
PBS-T (PBS with .05% Tween20) and 100 ml of 1:100 diluted
samples were added in duplicate to each ganglioside and control
wells. Following overnight incubation at 4uC, plates were washed 6
times and 100 ml of 0.1% BSA containing 0.25 mg of HRP
conjugated goat anti-human IgG (KPL) was added and incubated
for two hours at 4uC. Following washing, 100 ml of substrate
ABTS+H2O2 (KPL) was added to each well and after an
additional 30 minutes incubation at room temperature, absor-
bance (OD405) was measured (Molecular Devices). Net OD was
calculated by subtracting the OD values of control well from the
ganglioside-coated wells. Data are expressed as net OD405 at 1:100
serum dilutions.
Campylobacter Speciation and Serotyping
Biochemical speciation of Campylobacter isolates was confirmed
using a two-step Polymerase Chain Reaction (PCR) based test
[15]. A region in the 16S rRNA was amplified and digested with
the endonucleases DdeI, BsrI, and TaqI. Resulting PCR products
were separated by gel electrophoresis, stained with ethidium
bromide and visualized by UV. Patterns were then evaluated by
comparison to reference standards. Identification of C jejuni or C
Campylobacterosis and GBS
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the aspartyl kinase gene (asp). All Campylobacter isolates were
serotyped using the methods of Penner and Lior [16,17].
Definitions
Subjects were thought to possess luxury items if they owned
three or more of the following: washing machine, sewing machine,
oven, apartment, farmland, other land, or cell phone. Participants
owned livestock if they kept goats, cows, ducks, pigeons, etc.
Patients produced antiganglioside antibodies if the net OD
(gangliosides coated wells – control wells) readings was ..01, the
detectable limit of the assay, while those not producing
antiganglioside antibodies were patients with an OD of #0.1.
To be consistent with a previous study, a diarrhea case was a
patient with a history of diarrhea in the three months preceding
admission [18]. Campylobacter-associated diarrhea was defined as
isolating Campylobacter from a patient reporting diarrhea.
Statistical Analysis
A conditional multivariate logistic regression model that
accounts for the lack of sampling independence from matching
was used to compare cases to controls for demographic
characteristics, diarrhea prevalence, etc. [19]. A univariate odds
ratio was obtained by adding a single dependent (i.e., case or
controls status) and independent variable to the model. When
controlling for confounders, additional independent variables were
added including, unless stated otherwise, gender, livestock
ownership, and possession of luxury items.
When doing a subgroup analysis of cases and controls (e.g.,
cases and control with diarrhea) matching by age and hospital was
incomplete. In this situation, we employed a multivariate
unconditional regression and fit age and hospital of admission.
Because age was not normally distributed, this variable was fit as a
categorical variable: ,5 year old (infants and toddlers), 5 to ,13
years (children), 13 to ,18 (teenagers), and 18 or older (adults).
For all models, the 95% confidence intervals and p-values were
obtained from the model parameters.
When comparing cases to controls by IgM serum antibody
titers, we used linear regression with Generalized Estimating
Equations because of matching [20,21]. Univariate models
included a single dependent (i.e., normal log of serum IgM titer).
For all multivariate models, gender, livestock ownership, and
possession of luxury items were included. When completing a
subgroup analysis (e.g., only cases and control with diarrhea) age
and hospital of admission were added to the model.
When analyzing only case data (e.g., Campylobacter excretion), an
unconditional multivariate logistic regression was used. The values
for univariate and multivariate models were calculated as the
conditional regression model described earlier.
The distribution of Campylobacter species and serotypes for cases
and controls were compared using a Fisher’s exact test since cell
sizes were small (i.e., ,5). A sign rank test was employed to
compare the distribution of ages between cases and controls
expressing Campylobacter and the distribution of days from
admission to enrollment. To determine if diarrhea was more
common during warmer months and whether males were more
likely to have GBS than females, the exact p-value of a binomial
test of significance with binomial probability under the null
hypothesis of 0.5 was used [22]. A chi-square test was employed to
compare the clinical characteristics (e.g., mucoid stools, fever) of
cases and controls reporting diarrhea.
Statistical significance was two tailed with P,0.05. For analyses,
SAS version 9.1 (SAS Institute, Inc, Cary, North Carolina) or
StatXact version 4.01 (Cytel Software Corporation, Cambridge,
Massachusetts) was used. For graphing, SigmaPlot version 8.0
(SPPS, Inc, Chicago, Illinois) was employed.
Results
Enrollees
Neurologists identified 138 GBS patients of which 133 (96.4%)
including one case of Miller-Fisher Syndrome were enrolled (one
declined to participate, three had normal NCV, and one was
infected with Shigella flexneria). Out of 401 matched-controls, 374
(93.3%) were enrolled (eight did not meet inclusion criteria and 19
were infected with Salmonella spp.) Rectal swabs and serum samples
were obtained from all enrollees.
Description of Cases
Of the cases, 120 (90.2%) received a NCV test (4 died and 9 left
the hospital before testing) with 76 (63.3%) found to have primary
demyelinating disease, 17 (14.2%) had primary axonal disease, 15
Table 1. Characteristics of cases and controls enrolled in study of Campylobacter infection and Guillain-Barre ´ Syndrome, the Arab
Republic of Egypt, April 2001 through September 2003.
Population characteristics All Cases and controls History of diarrhea Campylobacter positive
Cases (n=133) Controls (n=374) Cases (n=39) Controls (n=83) Cases (n=14) Controls (n=26)
Age (years)
a,b 4 (2 to 9) 4 (1 to 9) 4 (1 to 19) 3 (1 to 10) 4 (2.5 to 9) 1.5 (1.0 to 6.0)
Male (%) 60.2 57.0 56.4 51.8 78.7 53.9
Own livestock (%) 51.5 35.1
c 39.5 32.5 42.9 50.0
Possessed luxury items (%)
d 28.6 23.8 28.2 33.7 7.1 42.3
e
Ain Shams University, Children’s 12.0 12.3 20.5 22.9 14.3 11.5
Cairo University 36.8 35.8 18.0 19.3 50.0 38.5
Alexandria University 51.1 51.9 61.5 57.8 35.7 50.0
aMedian (interquartile range).
bPatients were matched to controls for age (62 years) and hospital for all cases and controls; matching was incomplete when analyzing subgroups (e.g., Cases and
controls with diarrhea).
cP=.002; Odds Ratio=1.86 (95% CI: 1.25 to 2.78), univariate unconditional logistic regression.
dOwned three or more luxury items (e.g., cell phone, car).
eP=.04; Odd Ratio=0.10 (95% CI: 0.01 to 0.93), univariate unconditional logistic regression.
doi:10.1371/journal.pone.0003674.t001
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12 (10.0%) patients.
GBS showed no seasonality (P=.20). GBS was more common
in males (60.2%, P=0.02). Twenty-one (15.8%) cases required
mechanical ventilation and 11 (8.3%) cases died.
Case and Control Characteristics
Cases ranged in age from 7 months to 77 years with a median of 4
years (IQR: 2 to 9) while controls ranged from 1 month to 75 years
with a median of 4 years (IQR: 1 to 9). (Table 1) Cases and controls
appeared similar for gender and possession of luxury items. Cases
were morelikelyto own livestock (P=0.002).Most cases and controls
werefromAlexandriaUniversityHospital(51.1%),followedbyCairo
University Hospitals (36.9%), and Ain Shams University Children’s
Hospital (12.0%). Median age of cases at the admitting hospital was 5
(IQR: 2 to 13), 4 (IQR: 2 to 5), and 2 (IQR: 1 to 6.5) years for
Alexandria, Cairo, and Ain Shams Pediatric Hospitals, respectively.
Diarrhea Episodes
Thirty-nine (29.5%) cases and 83 (22.5%) controls (1 case and 5
controls had incomplete diarrhea data) reported having diarrhea
with cases being 1.69 (95% CI: 1.04 to 2.75, P=0.03) times more
likely to have diarrhea after adjusting for confounding variables.
Diarrhea was more common during warmer months but only
reached statistical significance for controls, 63.9% (P=0.015), but
not for cases, 61.5% (P=.20). The number of days between
diarrhea onset and hospital admission was statistically similar for
cases (median=14, IQR: 2 to 35) and controls (median=14, IQR:
7 to 28). Among case and controls reporting diarrhea, there were
no statistically significant differences for reports of mucoid stools
(38.2% vs. 51.9%), bloody stools (14.3% vs. 11.5%), fever (43.2%
vs. 58.7%), or vomiting (18.4% vs. 30.1%).
Campylobacter Isolation and Serotypes
Campylobacter isolates were identified from 14 (10.5%) cases and
26 (7.0%) controls (ORa=1.66, 95% CI: 0.78 to 3.51, P=.19). Of
the Campylobacter isolates, C jejuni was isolated from 11 (78.6%)
cases and 23 (88.5%) control, while the remaining isolates were C
coli (P=0.65 for distribution by species). Six (42.8%) of 14 case
isolates and 7 (28.0%) of 25 control isolates (one control had
missing data) had diarrhea. We did not detect an association
between Campylobacter isolation and diarrhea.
There were 26 Penner:Lior serogroups identified. (Table 2) Of
these serogroups, 4 (3.0%) case strains and 1 (0.3%) control strain
were Penner:Lior 41:27, a C jejuni strain (P=0.02). None of the
other 25 serogroups were statistically associated with GBS.
Serum Antibody Responses
We detected significantly higher geometric mean, IgM serum
antibody titers in cases than controls (Geometric Mean Titers
(GMT): 8.18 vs. 7.25, P,0.0001). (Figure 1) Cases had higher
GMT when restricting the analysis to cases and controls reporting
diarrhea (GMT: 7.89 vs. 7.29, P=0.01) or excreting Campylobacter
(GMT: 8.51 vs. 7.43, P=0.01). These differences remained
statistically significant after adjusting for confounders.
Antiganglioside Responses
Except for GM2, the proportion of cases producing autoanti-
bodies against gangliosides was statistically greater for cases than
controls. (Table 3) The odds of having antiganglioside antibodies
for cases was 2.79 (95% CI: 1.77 to 4.40, P,0.0001), 4.39 (95%
CI: 2.59 to 7.45, P=0.047), 2.95 (1.77 to 4.90, P,0.0001), and
2.56 (95% CI: 1.29 to 5.07, P=0.007) for GM1, GD1a, GD1b,
and GT1b, respectively.
When limiting the analysis to patients reporting diarrhea,
antiganglioside antibody production was again higher in cases
than controls except for GM2. However, the difference was only
statistically significant for autoantibodies against GD1a
(ORa=5.18, 95% CI: 1.76 to 15.68, P=0.0037). When further
restricting the analysis to cases and controls excreting Campylobac-
ter, serum antibodies to gangliosides appeared substantially higher
in cases than controls and three of the five ganglioside types were
statistically significant. Cases were 5.17 (95% CI: 1.03 to 26.07,
P=0.047), 7.89 (95% CI: 1.16 to 53.65, P=0.04), and 23.84 (95%
CI: 2.46 to 231.25, P=0.006) times more likely than control to
produce autoantibodies against GM1, GD1a, and GD1b,
respectively.
Discussion
GBS is believed to be an autoimmune disease. During infection,
antibodies may be produced against lipo-oligosaccharides mole-
cules on the surface of some Campylobacter strains that mimic the
Table 2. Percent of each Penner and Lior (Penner:Lior)
Campylobacter serogroup isolated from Guillain-Barre ´
Syndrome cases and patient-controls, the Arab Republic of
Egypt, April 2001 through September 2003.
Penner:Lior Group Cases
a (n=133) Controls (n=374) P-value
b
%( n ) %( n )
1(10, 32, 47):42C
c 0 (0) 0.3 (1) 1.0
1(10, 44, 47):UTC 0 (0) 0.3 (1) 1.0
1:UTJ 0 (0) 0.5 (2) 1.0
2:125J 0 (0) 0.3 (1) 1.0
4 (13, 50):7J 0 (0) 0.3 (1) 1.0
5 (32):22J 0 (0) 0.3 (1) 1.0
5:UTJ 0 (0) 0.5 (2) 1.0
10(47): 69J 0 (0) 0.3 (1) 1.0
13:36J 0.8 (1) 0.3 (1) 0.5
13(50, 65):7J 0.8 (1) 0 (0) 0.3
14:57C 0 (0) 0.3 (1) 1.0
19:UTJ 0.8 (1) 0 (0) 0.3
19 (33): UTJ 0.8 (0) 0.3 (1) 1.0
22:UTJ 0.8 (1) 0.5 (2) 1.0
24:110C 0 (0) 0.3 (1) 1.0
32:22J 0 (0) 0.3 (1) 1.0
34:46C 0.8 (1) 0 (0) 0.3
37(56):28C 0 (0) 0.3 (1) 1.0
40:80J 0.8 (1) 0 (0) 0.3
41:27J 3.0 (4) 0.3 (1) 0.02
42:19J 0 (0) 0.5 (2) 1.0
46(47):95C 0.8 (1) 0 (0) 0.3
46(47):UTC 0 (0) 0.3 (1) 1.0
49:97C 0 (0) 0.3 (1) 1.0
53:UTJ 0 (0) 0.3 (1) 1.0
56:UTC 1.5 (2) 0 (0) 0.07
aOne case specimen and two controls specimens were not serotyped.
bFisher’s exact test.
cSubscript ‘‘J’’=C jejuni and subscript ‘‘C’’=Cc o l i .
doi:10.1371/journal.pone.0003674.t002
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then directed against peripheral nerve tissue leading to myelin
inflammation, conduction block, and in some cases, axonal
degradation. As not all Campylobacter infections lead to GBS, the
agent and host factors that induce pathogenesis remain unclear.
This study was implemented in Egypt where residents
repeatedly experience Campylobacter-associated diarrhea [2,24,25].
Since most studies of Campylobacter and GBS have been completed
in western developed countries, where infection and immunity is
uncommon, we had an opportunity to examine the association of
Figure 1. Natural log of IgM serum antibody titers against Campylobacter among Guillain-Barre ´ Syndrome cases and patient-
controls and among cases and controls reporting diarrhea or excreting Campylobacter, the Arab Republic of Egypt, April 2001
through September 2003.
doi:10.1371/journal.pone.0003674.g001
Table 3. Odds of having IgM serum antibodies against GMI, GM2, GD1a, GD1b, and GT1b gangliosides in Guillain-Barre ´ Syndrome
cases and patient-controls for all cases and controls, for patients reporting diarrhea, and for patients excreting Campylobacter, the
Arab Republic of Egypt, April 2001 through September 2003.
Antiganglioside
Antibodies All cases and controls History of diarrhea Campylobacter positive
Cases
(n=133)
Controls
(n=374)
Adjusted Odds
Ratio
a
Cases
(n=39)
Controls
(n=83)
Adjusted Odds
Ratio
b
Cases
(n=14)
Controls
(n=26) Adjusted Odds Ratio
c
GM1 45.9 25.9 2.79 (1.77 to 4.40)
d,e 35.9 26.5 1.62 (0.70 to 3.76) 50.0 15.4 5.17 (1.03 to 26.07)
f
GM2 11.3 13.7 0.77 (0.41 to 1.47) 2.6 16.9 0.14 (0.02 to 1.12) 7.1 11.5 0.50 (0.04 to 5.92)
GD1a 35.3 11.5 4.39 (2.59 to 7.45)
e 28.2 9.6 5.03 (1.67 to 15.18)
g 42.9 7.7 7.89 (1.16 to 53.65)
h
GD1b 30.8 13.1 2.95 (1.77 to 4.90)
e 18.0 15.6 1.37 (0.48 to 3.93) 57.1 7.7 23.84 (2.46 to 231.25)
i
GT1b 14.3 6.7 2.56 (1.29 to 5.07)
j 7.7 6.0 1.35 (0.29 to 6.36) 28.6 3.9 6.22 (0.60 to 64.97)
aConditional logistic regression controlling for age, gender, ownership of farm animals, and ownership of luxury items.
bUnconditional logistic regression controlling for age, gender, livestock ownership, and possession of luxury items.
cUnconditional logistic regression controlling for possession of luxury items. Other variable were excluded because of sparse data.
dOdds Ratio (95% CI).
e,.0001.
fP=0.047.
gP=.004.
hP=0.04.
iP=0.006.
jP=.007.
doi:10.1371/journal.pone.0003674.t003
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repeated exposure to Campylobacter.
When limiting our analysis to hospitals serving both children
and adults, most GBS cases occurred in toddlers. This observation
and observations from other developing countries contrasts [26]
reports from developed countries where GBS is primarily an adult
illness [1]. The age-specific incidence of campylobacterosis which
suggests a higher incidence in children living in developing
countries and a higher incidence in adults in developed countries
appear to correlate with the age-specific incidence of GBS.
We observed that patients in contact with livestock appeared at
increased risk of GBS suggesting that animal husbandry may be a
hazard for GBS in Egypt. We have previously demonstrated in
Egypt that exposure to farm animals increases the risk of
Campylobacter infection in children [2], which may link animal
husbandry to GBS.
More than one in five controls reported diarrhea and controls
had IgM antibodies against Campylobacter antigens further support-
ing the view that Campylobacter infection was common. Still, GBS
patients were 69% more likely to have diarrhea and had
significantly higher levels of serum antibodies against Campylobacter
and several nerve gangliosides. These results suggest that GBS
cases were more likely to be exposed to Campylobacter, some of
which may have been neruopathogenic strains that express lipo-
oligosaccharide mimics [3,27].
As Campylobacter exposure was more common in this setting, we
were able to compare immune responses between Campylobacter-
positive cases and Campylobacter-positive controls. Despite currently
excreting Campylobacter, suggesting current exposure, we detected
significantly raised anti-Campylobacter antibody titers and anti-
ganglioside antibodies in cases. A more vigorous antibody-
mediated immunity in cases relative to controls may have been
due to a greater proportion of case strains expressing lipopolysac-
charide mimics or other antigenic variations [28], cases had a
greater genetic susceptibility or other host factors to a virulent
infection. However, studies of a genetic predisposition to GBS,
such as HLA type, have had limited success [29,30].
We identified a diversity of Penner:Lior serotypes but did not
identify a Campylobacter serotype associated with a significant
number of GBS cases as has been reported elsewhere [31,32]. A
Penner serotype O:41 (i.e., 41:27), C jejuni, was statistically
associated with GBS. This serotype has been isolated from GBS
cases in South Africa [33,34] and is reported to have lipopolysac-
charides that mimic the GM1 ganglioside [35]. Penner serotypes
O:1, O:2, O:4, O:10, and O:37 were recovered, and these strains
have been reported to be associated with GBS, but we found these
isolates only in control stools [3,18,36–39]. This observation
demonstrates the need for studies with comparison populations.
The severity of GBS in Egypt appears similar to that reported
from developing countries [40]. The proportion ventilated, about
16%, and the proportion that died, about 8%, is similar to the
20% ventilation rate and 5% to 10% case fatality ratio suggested
for developed countries [5,41].
Before stating our conclusions, we identify study limitations. We
have shown that Campylobacter are excreted for about 14 days after
infection in Egypt, and it is likely that patient stopped excreting
Campylobacter before admission [2]. Thus, Campylobacter excretion is
likely higher in cases than reported here. As we interviewed
hospital patients, and they were told the study objectives during
informed consent, it may be that recall bias increased the
frequency of diarrhea reports. Our conclusions could have been
inaccurate due to enrollment or case-ascertainment bias, but all
cases of acute flaccid paralysis were evaluated, and we had 96%
enrollment. Case ascertainment, clinical evaluation, and study
implementation could have differed between hospitals thereby
biasing the results. To mitigate these differences, we employed
identical training, uniform study specific procedures, and central-
ized supervision.
In conclusion, Campylobacter isolation rates and diarrhea histories
in our Egyptian patient population suggested that Campylobacter-
associated infections are not rare. Still, even with widespread
exposure to Campylobacter, Campylobacter infections appeared
associated with induction of antiganglioside antibodies that may
have triggered paralysis.
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